MedPath

Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc. logo
🇯🇵Japan
Ownership
Public
Established
1847-01-01
Employees
5K
Market Cap
-
Website
http://www.hisamitsu.co.jp

Clinical Trials

62

Active:0
Completed:30

Trial Phases

4 Phases

Phase 1:3
Phase 2:15
Phase 3:34
+1 more phases

Drug Approvals

8

CANADA:3
PHILIPPINES:2

Drug Approvals

SALONPAS GEL-PATCH

Approval Date
Feb 1, 2002
CANADA

SALONPAS - PLS TOP

Approval Date
Aug 3, 1995
CANADA

SALONPAS MEDICATED PLASTER

Approval Date
Dec 31, 1955
CANADA

Clinical Trials

Distribution across different clinical trial phases (55 trials with phase data)• Click on a phase to view related trials

Phase 3
34 (61.8%)
Phase 2
15 (27.3%)
Phase 1
3 (5.5%)
phase_1_2
1 (1.8%)
phase_2_3
1 (1.8%)
Phase 4
1 (1.8%)

Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail

Phase 2
Completed
Conditions
Onychomycosis
Interventions
Drug: HTU-520 Patch
Other: Placebo Patch
First Posted Date
2011-07-22
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
182
Registration Number
NCT01400594
Locations
🇺🇸

Total Skin and Beauty Dermatology Center, Birmingham, Alabama, United States

🇺🇸

Radiant Research, Inc., San Antonio, Texas, United States

🇺🇸

UAB Department of Dermatology, Birmingham, Alabama, United States

and more 24 locations

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

Phase 4
Completed
Conditions
Ankle Sprain
Interventions
Drug: FS-67 Patch
Other: Placebo Patch
First Posted Date
2009-12-23
Last Posted Date
2022-10-06
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
252
Registration Number
NCT01037816
Locations
🇺🇸

Hisamitsu Investigator Site, Grapevine, Texas, United States

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

Phase 3
Completed
Conditions
Ankle Sprain
Interventions
Other: Placebo Patch
First Posted Date
2009-06-25
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
240
Registration Number
NCT00927641
Locations
🇺🇸

Hisamitsu Investigator Site, Danville, Virginia, United States

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

Phase 3
Completed
Conditions
Osteoarthritis of the Knee
Interventions
Other: Placebo Patch
First Posted Date
2008-11-18
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
380
Registration Number
NCT00792727
Locations
🇺🇸

Hisamitsu Investigator Site, Yakima, Washington, United States

HKT-500 in Adult Patients With Shoulder Pain

Phase 3
Completed
Conditions
Pain
Interventions
Other: Placebo Patch
Drug: HKT-500 Ketoprofen Topical Patch
First Posted Date
2008-05-20
Last Posted Date
2015-06-04
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Target Recruit Count
368
Registration Number
NCT00680472
Locations
🇺🇸

Hisamitsu Investigator Site, Newport News, Virginia, United States

🇺🇸

Hisamitsu Pharmaceutical Co., Inc., Orange City, Florida, United States

🇺🇸

HIsamitsu Pharmaceutical Co., Inc., Perrysburg, Ohio, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.